Similar articles

• [Malignant neuroleptic syndrome associated to risperidone].

  Aguirre C, García Monco JC, Mendibil B. Aguirre C, et al. Med Clin (Barc). 1998 Feb 21;110(6):239. Med Clin (Barc). 1998. PMID: 9547739 Spanish. No abstract available.
• Neuroleptic malignant syndrome with risperidone.

  Gleason PP, Conigliaro RL. Gleason PP, et al. Pharmacotherapy. 1997 May-Jun;17(3):617-21. Pharmacotherapy. 1997. PMID: 9165568
• Risperidone and neuroleptic malignant syndrome.

  Tarsy D. Tarsy D. JAMA. 1996 Feb 14;275(6):446. JAMA. 1996. PMID: 8627964 No abstract available.
• [Neuroleptic malignant syndrome-dopamine-serotonin syndrome--the physiopathology, diagnosis, and therapy].

  Naito Y. Naito Y. Seishin Shinkeigaku Zasshi. 1997;99(10):803-8. Seishin Shinkeigaku Zasshi. 1997. PMID: 9465737 Review. Japanese. No abstract available.
• Neuroleptic malignant syndrome.

  Bristow MF, Kohen D. Bristow MF, et al. Br J Hosp Med. 1996 Apr 17-30;55(8):517-20. Br J Hosp Med. 1996. PMID: 8732227 Review.